WALTHAM, Mass.--(BUSINESS WIRE)--EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback